MAPT and Alzheimer disease: Moreover, TREM2 is connected to Aβ plaque structure and the aggregation of hyper-phosphorylated tau, hallmarks of AD progression [8,10,13]; indeed, TREM2 has been highlighted as the target of a novel therapeutic strategy for AD progression [9].